Health

OpenClinica CEO Cal Collins Chosen to Present at DIA 2023

Leave a comment


“SMART on FHIR improves the clinical workflow, enables clinical trials to integrate RWD in a non-disruptive way, and ultimately reduces burnout among clinical trial researchers.”


WALTHAM, Mass. (PRWEB)

OpenClinica proudly announces CEO Cal Collins is speaking at the DIA 2023 Global Annual Meeting in Boston, MA, June 25-29. Collins, a steering committee member of the Vulcan Program, Health Level Seven’s (HL7) newest Fast Healthcare Interoperability (FHIR) Accelerator, will discuss how SMART on FHIR is the key to unlocking real-world data. His session, SMART on FHIR: Integrating Electronic Health Records as Real-World Data, also includes:


  • Elise Berliner, Global Senior Principal for Real World Evidence Strategy, Cerner Enviza, who will share perspective on patient registries in the era of electronic health record (EHR) big data,

  • Dave deBronkart, “e-Patient Dave,” who is a patient advocate, cancer survivor and founding member of the HL7 FHIR Patient Empowerment Workgroup, the BMJ patient advisory panel and the Society for Participatory Medicine, and

  • Nicholas Rattenni, Senior Advisory Consultant, NNIT.


–

“I am honored DIA Global chose me to highlight the tremendous impact of SMART on FHIR on the usefulness of real-world data,” said Cal Collins, OpenClinica CEO. “SMART on FHIR improves the clinical workflow, enables clinical trials to integrate RWD in a non-disruptive way, and ultimately reduces burnout among clinical trial researchers.”

DIA 2023 is the largest global multidisciplinary event for life sciences professionals. Conference organizers expect 5,000+ global attendees.

For more information about Collins’ DIA 2023 Session, June 27, 4:00 – 5:00 pm, click here. To schedule a time to discuss SMART on FHIR with Collins and the OpenClinica team, visit: https://www.openclinica.com/contact-us/

ABOUT OPENCLINICA

OpenClinica accelerates clinical trials by automating data acquisition through its software-as-a-service platform. Offering a secure bridge between healthcare and research, OpenClinica is trusted by the world’s foremost life science companies, academic institutions, and government entities and has been used in more than 10,000 studies involving over five million patients. OpenClinica is proud to support hundreds of small, midsize and large research organizations spanning biotech, pharma, medical device manufacturing and contract research organizations. For more information, visit us at http://www.openclinica.com

Share article on social media or email:

Leave a Reply